Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when HAE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsHaemonetics reports Q4 and fiscal 2026 earnings results
Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read
Key Changes
-
high
Haemonetics announced financial results for the fourth quarter and full fiscal year ended March 28, 2026, via press release. Specific financial metrics are contained in the attached exhibit.
Item 2.02 verify on EDGAR →
Summary
Haemonetics Corporation filed an 8-K on May 7, 2026, to announce its fourth quarter and full fiscal year 2026 financial results. The filing references a press release (Exhibit 99.1) that contains the actual financial metrics and performance details for the period ended March 28, 2026. This is a standard earnings announcement filing required under SEC regulations.
Retail investors should review the attached press release for specific revenue, earnings, and guidance figures to assess the company's operational performance. Key items to watch include year-over-year growth trends, margin performance, and any forward guidance provided by management. The company may also host an earnings call to discuss results in detail, which would provide additional context on business momentum and strategic priorities heading into fiscal 2027.
Section-by-Section Diff
Event · Item 2.02 — Results of Operations and Financial Condition
Item 2.02 — Results of Operations and Financial Condition filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 7, 2026, Haemonetics Corporation issued a press release announcing financial results for the fourth quarter and fiscal year ended March 28, 2026.
Haemonetics disclosed financial results for the fourth quarter and full fiscal year ending March 28, 2026. The actual financial metrics are contained in the press release (Exhibit 99.1), which is not included in this 8-K body. This is a standard earnings announcement filing.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Press Release of Haemonetics Corporation dated May 7, 2026 announcing financial results for the fourth quarter and fiscal year ended March 28, 2026.
Haemonetics disclosed financial results for the fourth quarter and full fiscal year ended March 28, 2026 through a press release. The 8-K filing itself does not contain the actual financial figures; those details are in the attached Exhibit 99.1 press release.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify